- Home
- CBFV vs ACHV Comparison
CBFV vs ACHV Comparison
Compare CBFV & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBFV
- ACHV
- Stock Information
- Founded
- CBFV 1901
- ACHV N/A
- Country
- CBFV United States
- ACHV Canada
- Employees
- CBFV N/A
- ACHV N/A
- Industry
- CBFV Major Banks
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- CBFV Finance
- ACHV Health Care
- Exchange
- CBFV Nasdaq
- ACHV Nasdaq
- Market Cap
- CBFV 148.0M
- ACHV 126.9M
- IPO Year
- CBFV N/A
- ACHV N/A
- Fundamental
- Price
- CBFV $28.28
- ACHV $3.09
- Analyst Decision
- CBFV Hold
- ACHV Strong Buy
- Analyst Count
- CBFV 2
- ACHV 5
- Target Price
- CBFV $26.00
- ACHV $14.80
- AVG Volume (30 Days)
- CBFV 7.9K
- ACHV 277.4K
- Earning Date
- CBFV 01-29-2025
- ACHV 11-07-2024
- Dividend Yield
- CBFV 3.54%
- ACHV N/A
- EPS Growth
- CBFV 62.63
- ACHV N/A
- EPS
- CBFV 4.36
- ACHV N/A
- Revenue
- CBFV $67,214,000.00
- ACHV N/A
- Revenue This Year
- CBFV N/A
- ACHV N/A
- Revenue Next Year
- CBFV $0.21
- ACHV N/A
- P/E Ratio
- CBFV $6.48
- ACHV N/A
- Revenue Growth
- CBFV 24.04
- ACHV N/A
- 52 Week Low
- CBFV $20.75
- ACHV $3.04
- 52 Week High
- CBFV $33.72
- ACHV $5.59
- Technical
- Relative Strength Index (RSI)
- CBFV 44.20
- ACHV 29.72
- Support Level
- CBFV $26.53
- ACHV $3.12
- Resistance Level
- CBFV $28.65
- ACHV $3.86
- Average True Range (ATR)
- CBFV 0.50
- ACHV 0.21
- MACD
- CBFV 0.04
- ACHV -0.03
- Stochastic Oscillator
- CBFV 71.14
- ACHV 8.33
About CBFV CB Financial Services Inc.
CB Financial Services Inc operates as a bank holding company. The company conducts its operations through its wholly-owned subsidiary, Community Bank, a Pennsylvania-chartered commercial bank. The Bank offers products and services related to residential and commercial real estate loans, commercial and industrial loans, and consumer loans, as well as a range of deposit products for individuals and businesses in its market area. It operates in two operating units namely Community Banking and Insurance brokerage service segment. The bank generates its revenue in the form of interest.
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.